Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Index levels shift due to earnings, valuations, and macro surprises. Knowing the main drivers helps you anticipate potential reversals.
17,383 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A couple in their 40s discovers the $400,000 life policies bought in their 20s may no longer fit their evolving famil...
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
Compass International Holdings promotes Sue Yannaccone to chief operating officer after the $1.6 billion acquisition ...
Zenith Labs announced a new cross-chain bridge that lets the Canton network and Ethereum swap tokens via atomic swaps...
As planet labs (pl) 2026 nears, investors weigh growth against costs in a fast-evolving space data market. This guide...
Intel is resetting expectations around AI with a focus on edge infrastructure and domestic manufacturing, signaling a...
A trio of XRP ETFs began trading in 2026, offering exposure to XRP without direct coin ownership. This piece reviews ...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...
Meta Platforms is catching the eye of value-focused investors. This guide breaks down why meta stock could most under...
A seasoned fund boosted its stake in ZoomInfo, revealing a confident bet on GTM's growth story. This article explains...
A new working paper finds cfos admit privately that AI-related layoffs will rise ninefold this year, yet the total re...